Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-19 · Built: 2026-10-19 · 中文

← United States · Coverage record

US · SEC FORM 4

Syndax Pharmaceuticals Inc

SNDX · Nasdaq · CIK 0001395937 · Healthcare · Biotechnology

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

8 Form 4 transaction lines observed in the same window
5 sales · 3 option, withholding, award, gift or other lines

Last qualifying purchase2025-05-19 · Goldan Keith A. · value unavailable

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesModerate
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Botwood Nicholas A.J.Head of R&D, CMO
○▼○▼
Metzger Michael AChief Executive Officer
▼○▼
Goldan Keith A.Chief Financial Officer
▼
● Purchase▼ Sale○ Other

—

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2025-05-19 · Goldan Keith A..

Recent Form 4 activity

0Purchases
9Sales
17Other Form 4 lines
16SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING5 sale line(s) · context only
OTHER3 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
18,234,880
Previous report
20,660,449
Avg daily volume
2,152,633
Days to cover
8.5

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2025-05-19Katkin KeithPurchase (P)Common Stock10,000USD 9.11USD 91,100SEC filing ↗
2025-05-19Huber Martin H. Jr.Purchase (P)Common Stock5,000USD 8.99USD 44,950SEC filing ↗
2025-05-19Goldan Keith A.Purchase (P)Common Stock3,000USD —USD —SEC filing ↗
2025-05-16Botwood Nicholas A.J.Purchase (P)Common Stock11,765USD 9.00USD 105,885SEC filing ↗
2024-06-14Goldan Keith A.Purchase (P)Common Stock1,250USD 20.03USD 25,038SEC filing ↗
2021-04-26Meyers Michael L.Purchase (P)Common Stock500USD 15.46USD 7,730SEC filing ↗
2021-04-22Podlesak DennisPurchase (P)Common Stock13,967USD 14.11USD 197,074SEC filing ↗
2020-02-04Morrison BriggsPurchase (P)Common Stock12,500USD 8.00USD 100,000SEC filing ↗

Form 4 evidence

26 transaction lines in the latest 365-day window; 293 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-07-08Metzger Michael ASale (S)Common Stock32,375USD 24.24USD 784,770SEC filing ↗
2026-07-08Metzger Michael AOption exercise / conversion (M)Common Stock32,375USD 6.38USD 206,552SEC filing ↗
2026-06-12Botwood Nicholas A.J.Sale (S)Common Stock31,235USD 18.14USD 566,603SEC filing ↗
Show recent Form 4 evidence (23 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-07-08Metzger Michael ASale (S)Common Stock32,375USD 24.24USD 784,770SEC filing ↗
2026-07-08Metzger Michael AOption exercise / conversion (M)Common Stock32,375USD 6.38USD 206,552SEC filing ↗
2026-06-12Botwood Nicholas A.J.Sale (S)Common Stock31,235USD 18.14USD 566,603SEC filing ↗
2026-06-12Botwood Nicholas A.J.Option exercise / conversion (M)Common Stock31,235USD 13.82USD 431,668SEC filing ↗
2026-06-11Botwood Nicholas A.J.Sale (S)Common Stock34,280USD 18.00USD 617,040SEC filing ↗
2026-06-11Botwood Nicholas A.J.Option exercise / conversion (M)Common Stock22,515USD 13.82USD 311,157SEC filing ↗
2026-06-01Metzger Michael ASale (S)Common Stock6,847USD 18.99USD 130,025SEC filing ↗
2026-06-01Goldan Keith A.Sale (S)Common Stock1,177USD 18.99USD 22,351SEC filing ↗
2026-02-09Metzger Michael ASale (S)Common Stock17,159USD 21.03USD 360,854SEC filing ↗
2026-02-09Goldan Keith A.Sale (S)Common Stock3,410USD 21.03USD 71,712SEC filing ↗
2026-02-06Metzger Michael ASale (S)Common Stock7,412USD 20.62USD 152,835SEC filing ↗
2026-02-06Goldan Keith A.Sale (S)Common Stock2,082USD 20.62USD 42,931SEC filing ↗
2026-02-04Rizo AleksandraAward / grant (A)Common Stock24,000USD 0.00USD 0SEC filing ↗
2026-02-04Podlesak DennisAward / grant (A)Common Stock48,000USD 0.00USD 0SEC filing ↗
2026-02-04Metzger Michael AAward / grant (A)Common Stock217,600USD 0.00USD 0SEC filing ↗
2026-02-04Legault PierreAward / grant (A)Common Stock24,000USD 0.00USD 0SEC filing ↗
2026-02-04Katkin KeithAward / grant (A)Common Stock24,000USD 0.00USD 0SEC filing ↗
2026-02-04Jarrett JenniferAward / grant (A)Common Stock24,000USD 0.00USD 0SEC filing ↗
2026-02-04Huber Martin H. Jr.Award / grant (A)Common Stock24,000USD 0.00USD 0SEC filing ↗
2026-02-04Goldan Keith A.Award / grant (A)Common Stock52,250USD 0.00USD 0SEC filing ↗
2026-02-04Botwood Nicholas A.J.Award / grant (A)Common Stock60,000USD 0.00USD 0SEC filing ↗
2026-01-30Goldan Keith A.J (J)Common Stock1,219USD 8.48USD 10,337SEC filing ↗
2025-12-01Goldan Keith A.Gift (G)Common Stock1,224USD 0.00USD 0SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-19
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerSNDX
CIK0001395937
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNasdaq

Data coverage

Local Form 4 history293 transaction lines from 2020-01-31 to 2026-07-08
8 P purchase lines · 112 S sale lines · 173 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.